| Pharmaceutical active ingredients: |
| Estradiol Acetate |
| Available forms, composition and doses of Femring: |
| Insert, Extended Release; Vaginal; Estradiol Acetate 0.05 mg / 24 hInsert, Extended Release; Vaginal; Estradiol Acetate 0.1 mg / 24 h |
| Femring medical category: |
| Human:EstrogensOestrogens and progesterones and related synthetic drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA03 - Estradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GalenWarner Chilcott |
| Related documents and information about Femring: |
| Femring prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fempress | Moexipril Hydrochloride | Alpharma; Gebro Pharma; Globopharm |
| Fempress Plus | Hydrochlorothiazide; Moexipril Hydrochloride | Alpharma; Gebro Pharma |
| Fempro | Letrozole | Cipla |
| Fempropazine | Ethopropazine | Unidentified Pharmaceutical Company |
| Femranette Mikro | Ethinyl Estradiol; Levonorgestrel | Wyeth |
| Femsedin Kutz | Acetaminophen; Pamabrom; Pyrilamine Maleate | Quimica y Farmacia |
| Femsept | Estradiol Hemihydrate | Merck; Theramex Laboratoire |
| Femsept Combi | Estradiol Hemihydrate; Levonorgestrel | Merck; Theramex Laboratoire |
| Femsept Evo | Estradiol Hemihydrate; Levonorgestrel | Merck; Theramex Laboratoire |
| FemseptCombi | Estradiol Hemihydrate; Levonorgestrel | Merck; Theramex Laboratoire |